Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 3
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Life events and treatment prognosis for depression: A systematic review and individual patient data meta-analysis.
Buckman JEJ, Saunders R, Arundell LL, Oshinowo ID, Cohen ZD, O'Driscoll C, Barnett P, Stott J, Ambler G, Gilbody S, Hollon SD, Kendrick T, Watkins E, Eley TC, Skelton M, Wiles N, Kessler D, DeRubeis RJ, Lewis G, Pilling S. Buckman JEJ, et al. J Affect Disord. 2022 Feb 15;299:298-308. doi: 10.1016/j.jad.2021.12.030. Epub 2021 Dec 14. J Affect Disord. 2022. PMID: 34920035 Free PMC article. Review.
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D, Burns A, Tallon D, Lewis G, MacNeill S, Round J, Hollingworth W, Chew-Graham C, Anderson I, Campbell J, Dickens C, Macleod U, Gilbody S, Davies S, Peters TJ, Wiles N. Kessler D, et al. Health Technol Assess. 2018 Nov;22(63):1-136. doi: 10.3310/hta22630. Health Technol Assess. 2018. PMID: 30468145 Free PMC article. Clinical Trial.
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
Kessler DS, MacNeill SJ, Tallon D, Lewis G, Peters TJ, Hollingworth W, Round J, Burns A, Chew-Graham CA, Anderson IM, Shepherd T, Campbell J, Dickens CM, Carter M, Jenkinson C, Macleod U, Gibson H, Davies S, Wiles NJ. Kessler DS, et al. BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218. BMJ. 2018. PMID: 30381374 Free PMC article. Clinical Trial.
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
Tallon D, Wiles N, Campbell J, Chew-Graham C, Dickens C, Macleod U, Peters TJ, Lewis G, Anderson IM, Gilbody S, Hollingworth W, Davies S, Kessler D. Tallon D, et al. Trials. 2016 Feb 3;17:66. doi: 10.1186/s13063-016-1199-2. Trials. 2016. PMID: 26842107 Free PMC article. Clinical Trial.
Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
Rifkin-Zybutz R, MacNeill S, Davies SJ, Dickens C, Campbell J, Anderson IM, Chew-Graham CA, Peters TJ, Lewis G, Wiles N, Kessler D. Rifkin-Zybutz R, et al. J Psychopharmacol. 2020 Dec;34(12):1342-1349. doi: 10.1177/0269881120965939. Epub 2020 Nov 4. J Psychopharmacol. 2020. PMID: 33143538 Free PMC article. Clinical Trial.